SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jennifer Y.Y. Szeto, Loren Mowszowski, Moran Gilat, Courtney C. Walton, Sharon L. Naismith, Simon J.G. Lewis, Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 1, 31

    CrossRef

  2. 2
    Peter Hobson, Jolyon Meara, Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort, International Journal of Geriatric Psychiatry, 2015, 30, 6
  3. 3
    J. Gratwicke, M. Jahanshahi, T. Foltynie, Parkinson's disease dementia: a neural networks perspective, Brain, 2015,

    CrossRef

  4. 4
    C. O'Callaghan, M. Bertoux, M. Hornberger, Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 4, 371

    CrossRef

  5. 5
    H. C. V. Pfeiffer, A. Løkkegaard, M. Zoetmulder, L. Friberg, L. Werdelin, Cognitive impairment in early-stage non-demented Parkinson's disease patients, Acta Neurologica Scandinavica, 2014, 129, 5
  6. 6
    Roberta Biundo, Luca Weis, Silvia Facchini, Patrizia Formento-Dojot, Annamaria Vallelunga, Manuela Pilleri, Angelo Antonini, Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia, Parkinsonism & Related Disorders, 2014, 20, 4, 394

    CrossRef

  7. 7
    W.-J. Lee, Y.-Y. Chang, J.-J. Lin, Y.-F. Sung, J.-Y. Li, S.-J. Wang, R.-S. Chen, Y.-H. Yang, C.-J. Hu, C.-H. Tsai, H.-C. Wang, S.-L. Wu, M.-H. Chang, J.-L. Fuh, Comparison of activities of daily living impairments in Parkinson's disease patients as defined by the Pill Questionnaire and assessments by neurologists, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 9, 969

    CrossRef

  8. 8
    Inger van Steenoven, Dag Aarsland, Howard Hurtig, Alice Chen-Plotkin, John E. Duda, Jacqueline Rick, Lama M. Chahine, Nabila Dahodwala, John Q. Trojanowski, David R. Roalf, Paul J. Moberg, Daniel Weintraub, Conversion between Mini-Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 scores in Parkinson's disease, Movement Disorders, 2014, 29, 14
  9. 9
    Dong Xu, Michael H. Cole, Kerrie Mengersen, Peter A. Silburn, Feng Qiu, Cara Graepel, Graham K. Kerr, Executive Function and Postural Instability in People with Parkinson’s Disease, Parkinson's Disease, 2014, 2014, 1

    CrossRef

  10. 10
    Michele T. M. Hu, Konrad Szewczyk-Królikowski, Paul Tomlinson, Kannan Nithi, Michal Rolinski, Clara Murray, Kevin Talbot, Klaus P. Ebmeier, Clare E. Mackay, Yoav Ben-Shlomo, Predictors of cognitive impairment in an early stage Parkinson's disease cohort, Movement Disorders, 2014, 29, 3
  11. 11
    Johann Lehrner, Heidemarie Zach, Doris Moser, Andreas Gleiß, Eduard Auff, Walter Pirker, Gisela Pusswald, Prevalence of Mild Cognitive Impairment Subtypes in Patients with Parkinson’s Disease – Comparison of two Modes of Classification, Zeitschrift für Neuropsychologie, 2014, 25, 1, 49

    CrossRef

  12. 12
    Thomas E. Cope, Manon Grube, Arnab Mandal, Freya E. Cooper, Una Brechany, David J. Burn, Timothy D. Griffiths, Subthalamic deep brain stimulation in Parkinson׳s disease has no significant effect on perceptual timing in the hundreds of milliseconds range, Neuropsychologia, 2014, 57, 29

    CrossRef

  13. 13
    Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda, James E. Galvin, The spectrum of cognitive impairment in Lewy body diseases, Movement Disorders, 2014, 29, 5
  14. 14
    Olivier Godefroy, Laura Gibbons, Momar Diouf, David Nyenhuis, Martine Roussel, Sandra Black, Jean Marc Bugnicourt, Validation of an integrated method for determining cognitive ability: Implications for routine assessments and clinical trials, Cortex, 2014, 54, 51

    CrossRef

  15. 15
    Jennifer G. Goldman, Samantha Holden, Bryan Bernard, Bichun Ouyang, Christopher G. Goetz, Glenn T. Stebbins, Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease, Movement Disorders, 2013, 28, 14
  16. 16
    Christos T. Nakas, John C. Dalrymple-Alford, Tim J.  Anderson, Todd A. Alonzo, Generalization of Youden index for multiple-class classification problems applied to the assessment of externally validated cognition in Parkinson disease screening, Statistics in Medicine, 2013, 32, 6
  17. 17
    Éva M. Szegő, Tiago F. Outeiro, Pawel Kermer, Jörg B. Schulz, Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice, Neurobiology of Aging, 2013, 34, 2, 589

    CrossRef

  18. 18
    Connie Marras, Melissa J. Armstrong, Christopher A. Meaney, Susan Fox, Brandon Rothberg, William Reginold, David F. Tang-Wai, David Gill, Paul J. Eslinger, Cindy Zadikoff, Nancy Kennedy, Fred J. Marshall, Mark Mapstone, Kelvin L. Chou, Carol Persad, Irene Litvan, Benjamin T. Mast, Adam T. Gerstenecker, Sandra Weintraub, Sarah Duff-Canning, Measuring mild cognitive impairment in patients with Parkinson's disease, Movement Disorders, 2013, 28, 5
  19. 19
    Kurt A. Jellinger, Mild cognitive impairment in Parkinson disease: heterogenous mechanisms, Journal of Neural Transmission, 2013, 120, 1, 157

    CrossRef

  20. 20
    A. J. Yarnall, L. Rochester, D. J. Burn, Mild cognitive impairment in Parkinson's disease, Age and Ageing, 2013, 42, 5, 567

    CrossRef

  21. 21
    Ramón Fernández de Bobadilla, Javier Pagonabarraga, Saül Martínez-Horta, Berta Pascual-Sedano, Antonia Campolongo, Jaime Kulisevsky, Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment, Movement Disorders, 2013, 28, 10
  22. 22
    Dinora A. Morales, Yolanda Vives-Gilabert, Beatriz Gómez-Ansón, Endika Bengoetxea, Pedro Larrañaga, Concha Bielza, Javier Pagonabarraga, Jaime Kulisevsky, Idoia Corcuera-Solano, Manuel Delfino, Predicting dementia development in Parkinson's disease using Bayesian network classifiers, Psychiatry Research: Neuroimaging, 2013, 213, 2, 92

    CrossRef

  23. 23
    Kathy Dujardin, Albert F.G. Leentjens, Carole Langlois, Anja J.H. Moonen, Annelien A. Duits, Anne-Sophie Carette, Alain Duhamel, The spectrum of cognitive disorders in Parkinson's disease: A data-driven approach, Movement Disorders, 2013, 28, 2
  24. 24
    Sujung Yeo, Sabina Lim, Il-Hwan Choe, Yeong-Gon Choi, Kyung-Cheon Chung, Geon-Ho Jahng, Sung-Hoon Kim, Acupuncture Stimulation on GB34 Activates Neural Responses Associated with Parkinson's Disease, CNS Neuroscience & Therapeutics, 2012, 18, 9
  25. 25
    Jennifer G. Goldman, Holly Weis, Glenn Stebbins, Bryan Bernard, Christopher G. Goetz, Clinical differences among mild cognitive impairment subtypes in Parkinson's disease, Movement Disorders, 2012, 27, 9
  26. 26
    Per Svenningsson, Eric Westman, Clive Ballard, Dag Aarsland, Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment, The Lancet Neurology, 2012, 11, 8, 697

    CrossRef

  27. 27
    Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben A. Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C. Rodriguez-Oroz, David J. Burn, Roger A. Barker, Murat Emre, Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, Movement Disorders, 2012, 27, 3
  28. 28
    Kurt Jellinger, Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease, Journal of Neural Transmission, 2012, 119, 3, 381

    CrossRef

  29. 29
    Kurt A Jellinger, Neurobiology of cognitive impairment in Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1451

    CrossRef

  30. 30
    Kurt A. Jellinger, Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts, Movement Disorders, 2012, 27, 1
  31. 31
    Graeme JA Macphee, David A Stewart, Parkinson's disease: treatment and non-motor features, Reviews in Clinical Gerontology, 2012, 22, 04, 243

    CrossRef

  32. 32
    Toni L Pitcher, Tracy R Melzer, Michael R MacAskill, Charlotte F Graham, Leslie Livingston, Ross J Keenan, Richard Watts, John C Dalrymple-Alford, Tim J Anderson, Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study, Translational Neurodegeneration, 2012, 1, 1, 17

    CrossRef

  33. 33
    Michael R. MacAskill, Charlotte F. Graham, Toni L. Pitcher, Daniel J. Myall, Leslie Livingston, Saskia van Stockum, John C. Dalrymple-Alford, Tim J. Anderson, The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease, Neuropsychologia, 2012, 50, 14, 3338

    CrossRef

  34. 34
    William Reginold, Melissa J. Armstrong, Sarah Duff-Canning, Anthony Lang, David Tang-Wai, Susan Fox, Brandon Rothberg, Cindy Zadikoff, Nancy Kennedy, David Gill, Paul Eslinger, Mark Mapstone, Kelvin Chou, Carol Persad, Irene Litvan, Benjamin Mast, Connie Marras, The pill questionnaire in a nondemented Parkinson's disease population, Movement Disorders, 2012, 27, 10
  35. 35
    Daniel O. Claassen, Scott A. Wylie, Trends and Issues in Characterizing Early Cognitive Changes in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2012, 12, 6, 695

    CrossRef

  36. 36
    Elena Herrera, Fernando Cuetos, Javier Rodríguez-Ferreiro, Emotion recognition impairment in Parkinson's disease patients without dementia, Journal of the Neurological Sciences, 2011, 310, 1-2, 237

    CrossRef